A carregar...
Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies
Several mechanisms facilitate the progression of hormone-sensitive prostate cancer to castration-resistant prostate cancer (CRPC). At present, the approved chemotherapies for CRPC include systemic drugs (docetaxel and cabazitaxel) and agents that target androgen signaling, including enzalutamide and...
Na minha lista:
| Publicado no: | Am J Clin Exp Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4539108/ https://ncbi.nlm.nih.gov/pubmed/26309896 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|